In 2008, Zhangjiang Pharmaceutical Valley Chemical R&D Laboratory was established to help international pharmaceutical groups provide customized synthesis and chemical services.

In 2009, we operated process R&D services, focusing on commercial production scale up.

In 2010, the laboratory and production scale were enlarged, and a compound library was established.

In 2011, Jiangxi Qianshan Factory started construction, and gradually developed CRO and CDMO services.

In 2012, the Biocatalysis Research Center was established. In the same year, a similar GMP biocatalysis factory was built to optimize the product process and reduce the three wastes, and to innovate in science and technology.

In 2013, preclinical experiments and new drug research and development services were carried out, and the cooperative laboratory obtained GLP certification.

In 2014, the biocatalysis factory obtained ISO9001, ISO2000, Kosher and other related certifications.

In 2015, Shanghai Rochi sales platform was established, using international talents to serve multinational customers

In 2016, we cooperated with Shandong GMP and FDA factories, which passed the audits of Japan, South Korea, and the European Union to meet the diversified high-end needs of customers.

In 2017, cooperated with Huainan GMP factory to operate CXMO services for pharmaceutical intermediates and APIs.

In 2018, we cooperated with the supporting drug consistency evaluation platform and operated CMC services for preclinical and clinical research of new drugs.

In 2019, we cooperated with  4,000 square meters of pharmaceutical finished drug center, including research services such as tablets, capsules, ointments, etc.

In 2020, launched the drug development service of ADC (antibody drug conjugate) .

In 2021, Shanghai platform obtained ISO certificate.

In 2022, launched clinical and commercial services of peptide drugs, cells and gene therapy.